Login to Your Account

Sernova Breaks New Ground in Islet Cell Transplantation

By Catherine Shaffer
Staff Writer

Friday, August 17, 2012

Sernova Corp., of London, Ontario, is taking islet cell transplantation to the next level by combining transplanted insulin-producing islet cells with its Cell Pouch device in a Phase I/II trial in patients with Type I diabetes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription